Nicolas Fazilleau

Title: The Innovations of Nicolas Fazilleau

Introduction

Nicolas Fazilleau is a notable inventor based in La Salvetat Saint Gilles, France. He has made significant contributions to the field of medical research, particularly in understanding the relationship between human papillomavirus (HPV) and oral lichen planus (OLP). With a total of 2 patents, his work has implications for the diagnosis and treatment of patients suffering from this condition.

Latest Patents

Fazilleau's latest patents focus on the correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus. His research discovered a massive clonal expansion of activated CD8 T-cells, which showed an increased frequency of HPV 16-specific CD8 T-cells. This finding indicates a causal link between HPV infection and the dysimmune process associated with OLP. The inventions relate to compositions and methods for the diagnosis and treatment of OLP patients, providing new avenues for therapeutic intervention.

Career Highlights

Throughout his career, Nicolas Fazilleau has worked with prominent institutions such as Assistance Publique-Hôpitaux de Paris and Université Paris Diderot-Paris 7. His experience in these organizations has allowed him to collaborate with leading experts in the field, enhancing his research and innovation capabilities.

Collaborations

Some of his notable coworkers include Marie-Lise Gougeon and Manuelle Viguier. Their collaborative efforts have contributed to the advancements in understanding the immune response related to HPV and OLP.

Conclusion

Nicolas Fazilleau's contributions to medical research through his patents and collaborations highlight the importance of innovation in addressing complex health issues. His work continues to pave the way for improved diagnostic and treatment methods for patients with oral lichen planus.